Status:
COMPLETED
Comparison of Absorption of Vitamin D in Cystic Fibrosis
Lead Sponsor:
Emory University
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18-59 years
Phase:
PHASE4
Brief Summary
The investigators predict that a powder pill form of vitamin D will be more effectively absorbed than an oil form of vitamin D in people diagnosed with Cystic Fibrosis.
Detailed Description
The purpose of this study is to see how well two different forms of vitamin D work in Cystic Fibrosis (CF). Patients with Cystic Fibrosis have a hard time absorbing certain foods and often have low vi...
Eligibility Criteria
Inclusion
- Adult CF patients (age \>18 years
- Able to tolerate oral medication
- Expected to survive the duration of the study
Exclusion
- Inability to obtain or declined informed consent from the subject and/or legally authorized representative
- History of disorders associated with hypercalcemia
- Current hypercalcemia (albumin-corrected serum calcium \>10.8 mg/dL or ionized calcium \>5.2 mg/dL)
- Chronic kidney disease worse than stage III (\<60 ml/min), 7) Forced Expiratory Volume (FEV1)% predicted \<20%
- Current significant hepatic dysfunction total bilirubin \> 2.5 mg/dL with direct bilirubin \> 1.0 mg/dL
- Current use of cytotoxic or immunosuppressive drugs
- History of AIDS or illicit drug abuse
- too ill to participate in study based on investigator's or study team's opinion
- current enrollment in another intervention trial
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01880346
Start Date
October 1 2013
End Date
October 1 2015
Last Update
November 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322